216 related articles for article (PubMed ID: 33590875)
1. IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts.
Adami E; Viswanathan S; Widjaja AA; Ng B; Chothani S; Zhihao N; Tan J; Lio PM; George BL; Altunoglu U; Ghosh K; Paleja BS; Schafer S; Reversade B; Albani S; Ling ALH; O'Reilly S; Cook SA
Rheumatology (Oxford); 2021 Dec; 60(12):5820-5826. PubMed ID: 33590875
[TBL] [Abstract][Full Text] [Related]
2. IL11-mediated stromal cell activation may not be the master regulator of pro-fibrotic signaling downstream of TGFβ.
Tan Y; Mosallanejad K; Zhang Q; O'Brien S; Clements M; Perper S; Wilson S; Chaulagain S; Wang J; Abdalla M; Al-Saidi H; Butt D; Clabbers A; Ofori K; Dillon B; Harvey B; Memmott J; Negron C; Winarta D; Tan C; Biswas A; Dong F; Morales-Tirado V; Lu X; Singh G; White M; Ashley S; Knight H; Westmoreland S; Phillips L; Carr T; Reinke-Breen L; Singh R; Xu J; Wu K; Rinaldi L; Stoll B; He YD; Hazelwood L; Karman J; McCluskey A; Stine W; Correia I; Gauld S; Levesque MC; Veldman G; Hubeau C; Radstake T; Sadhukhan R; Fiebiger E
Front Immunol; 2024; 15():1293883. PubMed ID: 38455057
[TBL] [Abstract][Full Text] [Related]
3. Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc.
Liang R; Kagwiria R; Zehender A; Dees C; Bergmann C; Ramming A; Krasowska D; Michalska-Jakubus M; Kreuter A; Kraner ME; Schett G; Distler JHW
Ann Rheum Dis; 2019 Sep; 78(9):1269-1273. PubMed ID: 31177096
[TBL] [Abstract][Full Text] [Related]
4. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
[TBL] [Abstract][Full Text] [Related]
5. Elucidating the cellular mechanism for E2-induced dermal fibrosis.
Baker Frost D; Savchenko A; Ogunleye A; Armstrong M; Feghali-Bostwick C
Arthritis Res Ther; 2021 Feb; 23(1):68. PubMed ID: 33640015
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IL11 Signaling Reduces Aortic Pathology in Murine Marfan Syndrome.
Lim WW; Dong J; Ng B; Widjaja AA; Xie C; Su L; Kwek XY; Tee NGZ; Jian Pua C; Schafer S; Viswanathan S; Cook SA
Circ Res; 2022 Mar; 130(5):728-740. PubMed ID: 35135328
[TBL] [Abstract][Full Text] [Related]
7. IL11 Activates Pancreatic Stellate Cells and Causes Pancreatic Inflammation, Fibrosis and Atrophy in a Mouse Model of Pancreatitis.
Ng B; Viswanathan S; Widjaja AA; Lim WW; Shekeran SG; Goh JWT; Tan J; Kuthubudeen F; Lim SY; Xie C; Schafer S; Adami E; Cook SA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408908
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis.
Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
[TBL] [Abstract][Full Text] [Related]
11. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
12. Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
Sonnylal S; Denton CP; Zheng B; Keene DR; He R; Adams HP; Vanpelt CS; Geng YJ; Deng JM; Behringer RR; de Crombrugghe B
Arthritis Rheum; 2007 Jan; 56(1):334-44. PubMed ID: 17195237
[TBL] [Abstract][Full Text] [Related]
13. Antibody-mediated neutralization of IL11 signalling reduces ERK activation and cardiac fibrosis in a mouse model of severe pressure overload.
Lim WW; Corden B; Ye L; Viswanathan S; Widjaja AA; Xie C; Su L; Tee NGZ; Schafer S; Cook SA
Clin Exp Pharmacol Physiol; 2021 Apr; 48(4):605-613. PubMed ID: 33462828
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.
Zhang Y; Dees C; Beyer C; Lin NY; Distler A; Zerr P; Palumbo K; Susok L; Kreuter A; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2015 May; 74(5):936-43. PubMed ID: 24431397
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
[TBL] [Abstract][Full Text] [Related]
16. Promotion of Myofibroblast Differentiation and Tissue Fibrosis by the Leukotriene B
Liang M; Lv J; Jiang Z; He H; Chen C; Xiong Y; Zhu X; Xue Y; Yu Y; Yang S; Wang L; Li W; Guan M; Wan W; He R; Zou H
Arthritis Rheumatol; 2020 Jun; 72(6):1013-1025. PubMed ID: 31872544
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast-specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease.
Ng B; Dong J; Viswanathan S; Widjaja AA; Paleja BS; Adami E; Ko NSJ; Wang M; Lim S; Tan J; Chothani SP; Albani S; Schafer S; Cook SA
FASEB J; 2020 Sep; 34(9):11802-11815. PubMed ID: 32656894
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.
Beyer C; Zenzmaier C; Palumbo-Zerr K; Mancuso R; Distler A; Dees C; Zerr P; Huang J; Maier C; Pachowsky ML; Friebe A; Sandner P; Distler O; Schett G; Berger P; Distler JH
Ann Rheum Dis; 2015 Jul; 74(7):1408-16. PubMed ID: 24567525
[TBL] [Abstract][Full Text] [Related]
19. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase-1 regulates fibroblast activation in systemic sclerosis.
Zhang Y; Pötter S; Chen CW; Liang R; Gelse K; Ludolph I; Horch RE; Distler O; Schett G; Distler JHW; Dees C
Ann Rheum Dis; 2018 May; 77(5):744-751. PubMed ID: 29431122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
